Results 21 to 30 of about 1,232,742 (295)
Bacterial outer membrane vesicles and vaccine applications [PDF]
, 2014 Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Jose Luis Perez +30 more
core +3 more sources
Recent advances in lipopolysaccharide-based glycoconjugate vaccines [PDF]
, 2021 Introduction The public health burden caused by pathogenic Gram-negative bacteria is increasingly prominent due to antimicrobial resistance. The surface carbohydrates are potential antigens for vaccines against Gram-negative bacteria.
Pollard, Andrew +5 more
core +1 more source
Target identification for prevention and therapy of "Salmonella" infections [PDF]
, 2014 In this thesis we investigated maintenance requirements of Salmonella during chronic infections, and determined the relevant antigen properties that might facilitate the development of Salmonella vaccines. Overall, we wanted to achieve two goals: a)To
Barat, Somedutta
core +1 more source
mSphere, 2018 The native Invaplex (InvaplexNAT) vaccine and adjuvant is an ion exchange-purified product derived from the water extract of virulent Shigella species.
K. Ross Turbyfill +4 more
doaj +1 more source
EClinicalMedicine, 2021 Background: Shigellosis accounts for substantial morbidity and mortality worldwide and is the second most common cause of moderate and severe diarrhoea in children.
Robert W. Frenck, Jr +23 more
doaj +1 more source
Isolation, identification, and monitoring of antibiotic resistance in Pasteurella multocida and Mannheimia haemolytica isolated from sheep in East Azerbaijan province, Iran [PDF]
Archives of Razi Institute, 2016 The present study was carried out in order to isolate, identify, and assess the antimicrobial susceptibility of the causative agent(s) of pneumonic pasteurellosis in sheep in East Azerbaijan province, northwest of Iran.
I. Khalili +6 more
doaj +1 more source
BACTERIAL VACCINE THERAPY [PDF]
Journal of the American Medical Association, 1917 "If at the present time ten years of public notoriety have passed over any doctrine professing to be of importance in medical science, and if it has not succeeded in raising up a powerful body of able, learned, and ingenious advocates for its claims, the fault must be in the doctrine and not in the medical profession." This old criterion of Holmes is ...
openaire +2 more sources
Features of intellectual property protection mechanisms on the example of orphan drugs circulation
Фармакоэкономика, 2022 Objective: to study features of intellectual property protection mechanisms on the example of drugs for the treatment of rare (orphan) diseases.Material and methods.
D. S. Yurochkin +4 more
doaj +1 more source
Vaccines against bacterial meningitis [PDF]
British Medical Bulletin, 2004 Meningitis remains an important cause of morbidity and mortality among children >5 years of age and is especially prevalent in developing countries. Effective routine immunization against Hib, pneumococcus and serogroupC meningococcus has had a significant impact on both invasive disease and carriage caused by these encapsulated bacteria.
Segal, S, Pollard, A
openaire +3 more sources
A human Lyme disease vaccine: two steps forward on the path to prevention
Expert Review of VaccinesIntroduction Lyme disease is caused by the tick-borne spirochete pathogen Borrelia burgdorferi sensu lato (s.l.). Outer surface protein A (OspA) is expressed by B. burgdorferi s.l.
Raphael Simon +3 more
doaj +1 more source